There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
February 21, 2012 — TRENTON, N.J. (AP) — Johnson & Johnson's longtime CEO, Bill Weldon, is stepping down as the health care giant's top executive after an embarrassing string of recalls of everything from Tylenol to Benadryl over more than two years has
Vice Chairman Alex Gorsky, 51, will become CEO effective April 26, the date of J&;J's next board meeting, the company said. Gorsky was also nominated to the board, it added. Weldon, 63, remains the chairman. Johnson & Johnson CEO Bill Weldon is retiring
tool goes here FILE - In this Thursday Nov. 15, 2007 file photo, health care products maker Johnson & Johnson's CEO William Weldon poses for photos at the company's world headquarters in New Brunswick, N.J. The company on Tuesday, Feb. 21, 2012 said Weld
The maker of Listerine, Neutrogena and Johnson's baby products, said that Bill Weldon will remain chairman of the board for the time being, while ceding the chief executive post to Alex Gorsky, head of the medical device and diagnostics business. The off
Johnson & Johnson CEO Bill Weldon is retiring in April following an embarrassing string of product recalls that has stretched for more than two years, costing the health-care giant hundreds of millions of dollars and consumer trust. The maker of Band-Aid
A Muslim student organization at Rutgers University is voicing outrage in the wake of an Associated...- 5:40 pm The pool of prospective jurors was whittled down, a judge denied defense attorneys a motion to...- 5:28 pm The East Brunswick High School wres
The Monmouth County Board of Freeholders is expected to introduce a $487,850,000 annual budget...- 5:46 pm Hazlet native and celebrity chef David Burke of Rumson's David Burke Fromagerie will kick off "Food...- 5:37 pm - A new hotline for residents' sugg
Johnson & Johnson CEO Bill Weldon will step down April 26. NEW YORK (CNNMoney) -- Johnson & Johnson CEO Bill Weldon will step down in April, the pharmaceutical giant announced Tuesday. Alex Gorsky, J&J's head of pharmaceuticals in Europe, the Middle East
By Christopher M. Matthews The Department of Justice abandoned a foreign bribery case Tuesday, dropping prosecution of 16 businessmen charged in an undercover sting involving a phony military contract.The retreat is another blow to the Justice Department
* Vice Chair Gorsky to take over April 26 * Announcement comes days after latest product recall Feb 21 (Reuters) - Johnson & Johnson Chief Executive William Weldon will step down from his post in April after a series of recalls called into question the q
Alex Gorsky, worldwide chairman of medical devices for Johnson & Johnson, in Cleveland. Alex Gorsky, worldwide chairman of medical devices for Johnson & Johnson, in Cleveland. Photographer: David Maxwell/Bloomberg Johnson & Johnson (JNJ) named Alex Gorsk
After more than two years of controversy over manufacturing gaffes and product recalls, Bill Weldon is retiring as Johnson & Johnson ceo in April, ending a 10-year reign at the top of one of the most venerable, but now tarnished names, in corporate Ameri
U.S. Military Academy at West Point, NY, and spent six years in the U.S. Army. In 1996, he earned a Master of Business Administration (MBA) degree from the Wharton School of the University of Pennsylvania. Caring for the world, one person at a...
C. Weldon, chairman and CEO of Johnson & Johnson, participates in the APEC CEO Summit in Honolulu (Jason Reed Reuters, REUTERS / November 12, 2011) (Reuters) - Johnson & Johnson Chief Executive William Weldon will step down from his post in April after...
Johnson & Johnson (JNJ) has picked Alex Gorsky as its new CEO, according to a report just out from the Wall Street Journal citing an unidentified person familiar with the matter. Gorsky was one of two finalists for the job — the other being fellow Vice C
Johnson & Johnson’s Chief Executive William Weldon will step down from the post in April after a series of recalls called into question the quality of its products, from artificial hips to infants’ Tylenol, the Wall Street Journal reported on Tuesday.
To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool at the bottom of any article or visit www.djreprints.com Johnson & Johnson picked Alex Gorsky to be the next chief executive of...
Plans for a Tiger Town tailgate zone to enliven football weekends as Missouri ... Plans for a Tiger Town tailgate zone to enliven football weekends as Missouri ... The bottom line is in on the auction of the jersey Jeremy Lin wore the night he ... NEW...
If you can put the word market after it, I cover it. Weldon came under fire for recalls on products including Tylenol. Image by Getty Images North America via daylife Healthcare and consumer products giant Johnson & Johnson made a change at the top Tues
Weldon came under fire for recalls on products including Tylenol. Image by Getty Images North America via daylife Healthcare and consumer products giant Johnson & Johnson made a change at the top Tuesday, announcing that longtime Chief Executive Bill We
Johnson & Johnson (NYSE: JNJ) is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its corporate reputation,[citation needed] consistently... Full Article
A container of grape-flavored Infants' Tylenol liquid medicine with the enclosed syringe and flow restrictor is posed in Moreland Hills, Ohio on Friday, Feb. 17, 2012. A Johnson & Johnson consumer health business plagued by product recalls says it is pulling some versions of infant...
View Photo »Jack Vail poses with a box of grape-flavored Infants' Tylenol liquid medicine in Bainbridge Twp. , Ohio on Friday, Feb. 17, 2012. Johnson & Johnson is recalling all infant Tylenol on the U.S. market because some parents have had problems with newly designed bottles _ just introduced...
View Photo »This Jan. 22, 2012 photo shows Johnson & Johnson bath products for sale on a store shelf, in Springfield, Ill. Johnson & Johnson said Tuesday that fourth-quarter profit was barely a tenth what it made a year ago as a slew of charges for recalls, litigation and an acquisition dragged...
View Photo »William C. Weldon, chairman and CEO of Johnson & Johnson, participates in the APEC CEO Summit in Honolulu, Hawaii November 12, 2011.
View Photo »WAIKIKI, HI - NOVEMBER 12: Panel member Johnson & Johnson CEO William Weldon and journalist Patricia Janot take part in panel discussion Redefining Health: An Economic Asset and Competitive Advantage at the APEC CEO Summit 2001 meeting, part of the Asia-Pacific Economic Cooperation...
View Photo »Johnson & Johnson CEO William Weldon speaks during the CEO Summit at the Asia-Pacific Economic Cooperation (APEC) summit in Honolulu, Hawaii, on November 12, 2011. The United States is hosting this year's APEC forum for the first time since 1993, with leaders from the 21 member...
View Photo »Band-Aid products, made by Johnson & Johnson, are seen in a store in Brunswick, Maine, on Tuesday, Oct. 18, 2011. Johnson & Johnson's third-quarter profit fell 6 percent because larger overhead and production costs and a one-time charge offset higher foreign sales.
View Photo »Dr. Scott Ratzan, vice president of Global Health of Johnson & Johnson speaks during a discussion regarding initiatives to combat non-communicable diseases at the Clinton Global Initiative in New York, September 21, 2011.
View Photo »SUN VALLEY, ID - JULY 09: William 'Bill' Weldon, chief executive of Johnson & Johnson, attends the Allen & Company Media and Technology Conference on July 9, 2011 in Sun Valley, Idaho. The conference has been hosted annually by the investment firm Allen & Company each July since 1983. ...
View Photo »This undated image provided by Johnson & Johnson shows the CYPHER Sirolimus-eluting Coronary Stent. Johnson & Johnson said Wednesday, June 15, 2011 it will stop making and developing heart stents to focus on other stent types, a case of the pioneer in effect ceding that territory of the...
View Photo »NEW YORK, NY - JUNE 14: Akilah Peynado (L), a job recruiter with Johnson & Johnson, speaks with an attendee at the New York Sales Career Fair on June 14, 2011 in New York City. As mixed signals continue to emerge about the health of the US economy, reports show that US employers have...
View Photo »From left: Sarah Colamarino, Johnson & Johnson, Judy Meehan, National Healthy Mothers, Healthy Babies Coalition, and Stacie Paxton, Hill & Knowlton.
View Photo »WAIKIKI, HI - NOVEMBER 12: Panel members Yasuchika Hasegawa, (L) President & CEO of Takeda Pharmaceutical Company Limited and Johnson & Johnson CEO William Weldon and Journalist Patricia Janot take part in panel discussion Redefining Health: An Economic Asset and Competitive Advantage...
View Photo »WAIKIKI, HI - NOVEMBER 12: Panel members from left to right Dr. Toby Cosgrove, CEO of The Cleveland Clinic, Yasuchika Hasegawa, President & CEO of Takeda Pharmaceutical Company Limited and Johnson & Johnson CEO William Weldon and Journalist Patricia Janot take part in panel discussion...
View Photo »U.S. APEC Business Coalition members including Thomas J. Donohue, President and CEO, U.S. Chamber of Commerce, (L-R), William Weldon, Chairman and CEO of Johnson & Johnson, and John S. Chen, Chairman, CEO & President, Sybase, Inc. , attend a meeting with President Hu Jintao, President of...
View Photo »U.S. APEC Business Coalition members including Thomas J. Donohue, President and CEO, U.S. Chamber of Commerce, left to right:, William Weldon, Chairman and CEO of Johnson & Johnson, John S. Chen, Chairman, CEO & President, Sybase, Inc. , William V. Hickey, CEO of Sealed Air Corporation,...
View Photo »COMMERCIAL IMAGE - In this photograph taken by AP Images for AIDS Healthcare Foundation, Protestors from the AIDS Healthcare Foundation deliver a bag full of petitions requesting lower AIDS drug pricing to Johnson & Johnson headquarters in New Brunswick, NJ on Wednesday, Nov. 2, 2011.
View Photo »FILE - In this Oct. 18, 2011 file photo, First Aid products made by Johnson & Johnson, are displayed in a store in Brunswick, Maine. Johnson & Johnson announced Tuesday, Jan. 24, 2012, sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth...
View Photo »COMMERCIAL IMAGE - In this photograph taken by AP Images for the AIDS Healthcare Foundation, protesters from the AIDS Healthcare Foundation stage a "die-in" at Johnson & Johnson headquarters in New Brunswick, NJ on Friday, Sept. 30, 2011.
View Photo »COMMERCIAL IMAGE - In this photo taken by AP Images for the AIDS Healthcare Foundation, AIDS Healthcare Foundation protesters march at Johnson & Johnson Headquarters Tuesday, August 17, 2011 in New Brunswick NJ.
View Photo »Merrian Brooks, a fourth year medical student at Ohio University, holds up a sign as she protests outside of the Johnson & Johnson shareholders meeting, Thursday, April 28, 2011 in New Bruinswick, N.J. Members of PETA are also seen protesting outside of the Hyatt Regency Hotel.
View Photo »This undated photo provided by Boston Scientific Corp. , shows Michael Mahoney who will appointed president of Boston Scientific Corp. , Oct. 17, 2011. Boston Scientific Corp.'s choice of Johnson & Johnson executive Michael Mahoney to become its next leader drew praise from analysts...
View Photo »Swiss medical device company Synthes Chairman of the board Hansjoerg Wyss (L) and his daughter Amy attend the general shareholders meeting in Solothurn April 28, 2011. Johnson & Johnson is to buy Synthes Inc in a deal worth $21.3 billion, its largest ever buy, boosting its orthopaedics...
View Photo »Swiss medical device company Synthes Chairman of the board Hansjoerg Wyss speaks during the general shareholders meeting in Solothurn April 28, 2011. Johnson & Johnson is to buy Synthes Inc in a deal worth $21.3 billion, its largest ever buy, boosting its orthopaedics franchise and...
View Photo »A general view shows the headquarters of Swiss medical devices maker Synthes in Oberdorf April 25, 2011. Johnson & Johnson is to buy Synthes Inc for 19 billion Swiss francs ($21.59 billion) in its largest ever buy, boosting its orthopaedic business and reshaping the wider industry, the...
View Photo »A container of grape-flavored Infants' Tylenol liquid medicine with the enclosed syringe and flow restrictor is posed in Moreland Hills, Ohio on Friday, Feb. 17, 2012. A Johnson & Johnson consumer health business plagued by product recalls says it is pulling some versions of infant...
View Photo »They lost their son. They want justice. Johnson & Johnson says one thing and does another
We call on the remaining three companies we have invited to the table—Abbott, Merck, and Johnson & Johnson—to also enter into negotiations with the Pool.
The case often cited is the (1982) Tylenol poisoning case. Even though the maker had no direct connection to the poisoning, it responded in an open fashion with a massive recall. Many people say that over-response is an example of how (Tylenol maker Johnson & Johnson) built a perception of responsibilit...
Johnson & Johnson baby products will no longer include phthlates, quaternium-15, and reduce exposure to 1,4 dioxane. But they’ll still be a long way from natural, with ingredients like parabens on their labels.
